Industry News (RSS)

Regulatory Affairs


RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting.
Posted: May 29, 2023, 12:00 am
Invitae, a leading medical genetics company, announced that Chief Financial Officer Yafei Wen is resigning to pursue other opportunities, effective June 30, 2023.
Posted: May 26, 2023, 12:00 am
Biophytis SA announced that it has filed, through its pharmaceutical partner Intsel Chimos, an application for Early Access Authorisation in France with the French National Authority for Health for the use of Sarconeos [1] in the treatment of adult patients with a severe form of COVID-19, who are at risk of developing a critical form of the disease and for whom therapeutic alternatives are not appropriate.
Posted: May 26, 2023, 12:00 am
Japan Association for Cellular Agriculture, a Japan-based non-profit research institute hosted the inaugural meeting in Tokyo, in response to Japanese Prime Minister Fumio Kishida’s announcement in February 2023 of the intention to develop the domestic cultivated food industry.
Posted: May 26, 2023, 12:00 am
Genexine announced the publication of an abstract of its phase 2 clinical trial on triple combination neoadjuvant therapy for HNSCC in the ASCO.
Posted: May 26, 2023, 12:00 am


Neuralink, however closely watched, is still catching up to its peers in the neurotechnology field. 
Author: Lizzy Lawrence
Posted: May 26, 2023, 7:53 pm
In the latest edition of STAT's Health Tech newsletter: Omada tackles obesity drugs, Boston Scientific nixes deal, and Microsoft health leader on GPT.
Author: Mario Aguilar
Posted: May 26, 2023, 6:13 pm
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
Author: Ed Silverman
Posted: May 26, 2023, 3:53 pm
Millions of doses into the rollout of a new polio vaccine, it is apparent that the failure to vaccinate a sufficient proportion of children against the disease will not be…
Author: Helen Branswell
Posted: May 26, 2023, 2:08 pm
The European Medicines Agency recommended revoking marketing authorization for a Novartis sickle cell disease drug called Adakveo.
Author: Ed Silverman
Posted: May 26, 2023, 1:20 pm

Human Resources

The slowdown was the result of stock market performance and lingering economic uncertainties, the firm said.

Author: Emilie Shumway
Posted: May 26, 2023, 3:13 pm

Several other employers have settled similar DOJ claims in the past year: 30 employers in total have agreed to pay a collective $1.6 million in civil penalties.

Author: Kate Tornone
Posted: May 26, 2023, 2:54 pm

Nontraditional programs have helped many individuals land jobs, and Indeed’s new tool aims to both upskill and place workers.

Author: Carolyn Crist
Posted: May 26, 2023, 2:05 pm

KPMG’s head of talent and culture offers three pillars for equipping managers and all employees with resources to manage mental well-being.

Author: Sandy Torchia
Posted: May 26, 2023, 1:33 pm

The entry to the race of polarizing figures like Florida Governor Ron DeSantis may have HR on edge.

Author: Caroline Colvin
Posted: May 25, 2023, 7:54 pm